Literature DB >> 35355768

Wound Infection with Multi-Drug Resistant Clostridium Perfringens: A Case Study.

R Khandia1, N Puranik1, D Bhargava1, N Lodhi1, B Gautam1, K Dhama2.   

Abstract

Wound infections are among public health problems worldwide. However, progress has been made in improving surgical techniques and antibiotic treatments. Misuse/overuse of antibiotics to prevent and treat bacterial infections eventually leads to increased bacterial resistance with rising incidences of multi-drug resistant (MDR) bacterial strains. The wider dissemination of antibiotics may ultimately result in ineffectiveness to antibiotic therapy, thereby complicating/graving the outcome of a patient. In the present study, a 60-year-old male patient having wound infection with MDR bacterium that ultimately required surgical amputation of the toe was investigated. For the confirmation of MDR bacterium, two culture media viz., MacConkeyAgar and Mueller Hinton Agar media were used. The sensitivity of the isolated strain for various antibiotics was tested using the disc diffusion method. The wound sample was found positive for Gram-positive bacterium that was identified as Clostridium Perfringens. The bacterium was screened for 40 antibiotics, and among all the antibiotics, it was found sensitive for only Piperacillin/Tazobactam antibiotic combination. C. perfringens bacterium caused the gas gangrene in the infected wound part of the patient. Amputation of the gangrene -affected foot part was performed by surgery, and with good medical care, the person recovered fast. To the best of our knowledge, this is the first-ever report of MDR C. perfringens single isolate harboring resistance against at least 40 antibiotics tested. More research is needed to develop really new and effective medicines that do not cross-react with antibiotics now in use and have robust activity against MDR organisms.

Entities:  

Keywords:  Gas gangrene; Multi-drug resistance; Wound; Clostridium Perfringens

Mesh:

Substances:

Year:  2021        PMID: 35355768      PMCID: PMC8934091          DOI: 10.22092/ari.2021.355985.1757

Source DB:  PubMed          Journal:  Arch Razi Inst        ISSN: 0365-3439


  31 in total

1.  Clostridium perfringens gas gangrene at a wrist intravenous line insertion.

Authors:  Catherine Determann; Craig Andrew Walker
Journal:  BMJ Case Rep       Date:  2013-10-09

Review 2.  Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance.

Authors:  Chandradhish Ghosh; Paramita Sarkar; Rahaf Issa; Jayanta Haldar
Journal:  Trends Microbiol       Date:  2019-01-22       Impact factor: 17.079

3.  Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.

Authors:  Dennis L Stevens; Alan L Bisno; Henry F Chambers; E Patchen Dellinger; Ellie J C Goldstein; Sherwood L Gorbach; Jan V Hirschmann; Sheldon L Kaplan; Jose G Montoya; James C Wade
Journal:  Clin Infect Dis       Date:  2014-07-15       Impact factor: 9.079

4.  Molecular characterization and antimicrobial resistance profile of Clostridium perfringens type A isolates from humans, animals, fish and their environment.

Authors:  Jay Prakash Yadav; Suresh Chandra Das; Pankaj Dhaka; Deepthi Vijay; Manesh Kumar; Asish Kumar Mukhopadhyay; Goutam Chowdhury; Pranav Chauhan; Rahul Singh; Kuldeep Dhama; Satya Veer Singh Malik; Ashok Kumar
Journal:  Anaerobe       Date:  2017-05-17       Impact factor: 3.331

5.  Gas gangrene in patient with atherosclerosis obliterans.

Authors:  Masanori Niimi; Yosifumi Ikeda; Shigenao Kan; Hiroshi Takami
Journal:  Asian Cardiovasc Thorac Ann       Date:  2002-06

6.  Effect of antibiotics on toxin production and viability of Clostridium perfringens.

Authors:  D L Stevens; K A Maier; J E Mitten
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

7.  Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens.

Authors:  D L Stevens; B M Laine; J E Mitten
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

8.  Antibiotic Cycling and Antibiotic Mixing: Which One Best Mitigates Antibiotic Resistance?

Authors:  Robert Eric Beardmore; Rafael Peña-Miller; Fabio Gori; Jonathan Iredell
Journal:  Mol Biol Evol       Date:  2017-04-01       Impact factor: 16.240

9.  Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis.

Authors:  Miquel Serra-Burriel; Matthew Keys; Carlos Campillo-Artero; Antonella Agodi; Martina Barchitta; Achilleas Gikas; Carlos Palos; Guillem López-Casasnovas
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

Review 10.  Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria.

Authors:  Abid Ali Khan; Khanzadi Nazneen Manzoor; Aamir Sultan; Maria Saeed; Mahrukh Rafique; Sameen Noushad; Ayesha Talib; Simone Rentschler; Hans-Peter Deigner
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.